rs387906898

Variant summary

Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PM1PP3_ModeratePP5

The NM_020433.5(JPH2):​c.494C>T​(p.Ser165Phe) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000719 in 1,389,970 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S165Y) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000072 ( 0 hom. )

Consequence

JPH2
NM_020433.5 missense

Scores

12
6

Clinical Significance

Pathogenic no assertion criteria provided P:1

Conservation

PhyloP100: 7.48

Publications

30 publications found
Variant links:
Genes affected
JPH2 (HGNC:14202): (junctophilin 2) Junctional complexes between the plasma membrane and endoplasmic/sarcoplasmic reticulum are a common feature of all excitable cell types and mediate cross talk between cell surface and intracellular ion channels. The protein encoded by this gene is a component of junctional complexes and is composed of a C-terminal hydrophobic segment spanning the endoplasmic/sarcoplasmic reticulum membrane and a remaining cytoplasmic domain that shows specific affinity for the plasma membrane. This gene is a member of the junctophilin gene family. Alternative splicing has been observed at this locus and two variants encoding distinct isoforms are described. [provided by RefSeq, Jul 2008]
JPH2 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy 17
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • cardiomyopathy, dilated, 2E
    Inheritance: Unknown, AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • dilated cardiomyopathy
    Inheritance: SD Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 5 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 16 uncertain in NM_020433.5
PP3
MetaRNN computational evidence supports a deleterious effect, 0.93
PP5
Variant 20-44160293-G-A is Pathogenic according to our data. Variant chr20-44160293-G-A is described in ClinVar as Pathogenic. ClinVar VariationId is 30457.Status of the report is no_assertion_criteria_provided, 0 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020433.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
JPH2
NM_020433.5
MANE Select
c.494C>Tp.Ser165Phe
missense
Exon 2 of 6NP_065166.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
JPH2
ENST00000372980.4
TSL:5 MANE Select
c.494C>Tp.Ser165Phe
missense
Exon 2 of 6ENSP00000362071.3

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000719
AC:
10
AN:
1389970
Hom.:
0
Cov.:
32
AF XY:
0.00000583
AC XY:
4
AN XY:
685686
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31566
American (AMR)
AF:
0.00
AC:
0
AN:
35908
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35714
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79230
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
41860
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5050
European-Non Finnish (NFE)
AF:
0.00000928
AC:
10
AN:
1077792
Other (OTH)
AF:
0.00
AC:
0
AN:
57722
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

ClinVar submissions as Germline

Significance:Pathogenic
Revision:no assertion criteria provided
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
-
-
Hypertrophic cardiomyopathy 17 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
1.0
BayesDel_addAF
Pathogenic
0.33
D
BayesDel_noAF
Pathogenic
0.23
CADD
Pathogenic
31
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.64
D
Eigen
Uncertain
0.62
Eigen_PC
Uncertain
0.52
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
1.0
D
M_CAP
Pathogenic
0.76
D
MetaRNN
Pathogenic
0.93
D
MetaSVM
Uncertain
0.18
D
MutationAssessor
Uncertain
2.8
M
PhyloP100
7.5
PrimateAI
Pathogenic
0.93
D
PROVEAN
Pathogenic
-5.9
D
REVEL
Pathogenic
0.71
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.81
MutPred
0.76
Loss of phosphorylation at S165 (P = 0.0176)
MVP
0.93
ClinPred
1.0
D
GERP RS
3.3
Varity_R
0.87
gMVP
0.70
Mutation Taster
=16/84
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs387906898; hg19: chr20-42788933; API